Victory Capital Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$144.95 - $152.29 $1.04 Million - $1.09 Million	7,150 New	7,150 $1.08 Million
Q2 2022 Aug 01, 2022	SELL	$83.14 - $145.99 $213,170 - $374,318	-2,564 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$110.08 - $142.92 $17,062 - $22,152	155 Added 6.43%	2,564 $229,000
Q4 2021 Feb 07, 2022	BUY	$99.73 - $148.48 $240,249 - $357,688	2,409 New	2,409 $332,000
Q4 2019 Feb 04, 2020	SELL	$40.86 - $57.65 $49,644 - $70,044	-1,215 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$37.38 - $49.47 $45,416 - $60,106	1,215 New	1,215 $51,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.